Schizophrenia Research
Volume 81, Issue 2 , Pages 151-155 , 31 January 2006

Validity of the CAGE questionnaire in schizophrenic patients with alcohol abuse and dependence

  • Alain Dervaux

      Affiliations

    • Service d'addictologie, Centre Hospitalier Sainte-Anne, 1 Rue Cabanis, F 75014 Paris, France
    • Service de psychiatrie, BP 27, Centre hospitalier général, F 91401 Orsay, France
    • INSERM EMI 0117, 2 ter rue d'Alésia 75014 Paris, France
    • Corresponding Author InformationCorresponding author. Service d'addictologie, Centre Hospitalier Sainte-Anne, 1 Rue Cabanis, F 75014 Paris, France. Tel.: +33 1 45 65 80 64; fax: +33 1 45 65 88 32.
    • ,
  • Franck J. Baylé

      Affiliations

    • INSERM EMI 0117, 2 ter rue d'Alésia 75014 Paris, France
    • Université René Descartes (Paris V) Service Hospitalo-Universitaire de Santé Mentale et Thérapeutique Centre Hospitalier Sainte-Anne, 1 Rue Cabanis, F 75014 Paris, France
    • ,
  • Xavier Laqueille

      Affiliations

    • Service d'addictologie, Centre Hospitalier Sainte-Anne, 1 Rue Cabanis, F 75014 Paris, France
    • ,
  • Marie-Chantal Bourdel

      Affiliations

    • INSERM EMI 0117, 2 ter rue d'Alésia 75014 Paris, France
    • Université René Descartes (Paris V) Service Hospitalo-Universitaire de Santé Mentale et Thérapeutique Centre Hospitalier Sainte-Anne, 1 Rue Cabanis, F 75014 Paris, France
    • ,
  • Michèle Leborgne

      Affiliations

    • Service de psychiatrie, BP 27, Centre hospitalier général, F 91401 Orsay, France
    • ,
  • Jean-Pierre Olié

      Affiliations

    • INSERM EMI 0117, 2 ter rue d'Alésia 75014 Paris, France
    • Université René Descartes (Paris V) Service Hospitalo-Universitaire de Santé Mentale et Thérapeutique Centre Hospitalier Sainte-Anne, 1 Rue Cabanis, F 75014 Paris, France
    • ,
  • Marie-Odile Krebs

      Affiliations

    • INSERM EMI 0117, 2 ter rue d'Alésia 75014 Paris, France
    • Université René Descartes (Paris V) Service Hospitalo-Universitaire de Santé Mentale et Thérapeutique Centre Hospitalier Sainte-Anne, 1 Rue Cabanis, F 75014 Paris, France

Received 18 July 2005 ,Revised 10 September 2005 ,Accepted 14 September 2005.

References 

  1. Aertgeerts B, Buntinx F, Kester A. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. J. Clin. Epidemiol. 2004;57:30–39
  2. Barnaby B, Drummond C, McCloud A, Burns T, Omu N. Substance misuse in psychiatric inpatients: comparison of a screening questionnaire survey with case notes. BMJ. 2003;327:783–784
  3. Beresford TP, Blow FC, Hill E, Singer K, Lucey MR. Comparison of CAGE questionnaire and computer-assisted laboratory profiles in screening for covert alcoholism. Lancet. 1990;336:482–485
  4. Cantor-Graae E, Nordström LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr. Res. 2001;48:69–82
  5. DeQuardo JR, Carpenter CF, Tandon R. Patterns of substance abuse in schizophrenia: nature and significance. J. Psychiatr. Res. 1994;28:267–275
  6. Dervaux A, Baylé FJ, Laqueille X, Bourdel MC, Le Borgne MH, Olié JP, et al. Is substance abuse in schizophrenia related to impulsivity, sensation seeking or anhedonia?. Am. J. Psychiatr. 2001;158:492–494
  7. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry. 1991;148:224–230
  8. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr. Bull. 1990;16:57–67
  9. Duke PJ, Pantelis C, Barnes TRE. South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br. J. Psychiatry. 1994;164:630–636
  10. Etter M, Etter JF. Alcohol consumption and the CAGE test in outpatients with schizophrenia or schizoaffective disorder and in the general population. Schizophr. Bull. 2004;30:947–956
  11. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252:1905–1907
  12. Fiellin DA, Reid MC, O'Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch. Intern. Med. 2000;160:1977–1989
  13. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and life substance use in schizophrenia. Schizophr. Bull. 1998;24:443–455
  14. Gut-Fayand A, Dervaux A, Olié JP, Lôo H, Poirier MF, Krebs MO. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res. 2001;102:65–72
  15. Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biol. Psychiatry. 1996;40:1155–1163
  16. Kamali M, Kelly L, Gervin M, Browne S, Larkin C, O'Callaghan E. The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr. Scand. 2000;101:452–456
  17. Kavanagh DJ, Waghorn G, Jenner L, Chant DC, Carr V, Evans M, et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr. Res. 2004;66:115–124
  18. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276
  19. Kovasnay B, Fleischer J, Tanenberg-Karant M, Jandorf L, Miller AD, Bromet E. Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr. Bull. 1997;23:195–201
  20. Liskow B, Campbell J, Nickel EJ, et al. Validity of the CAGE questionnaire in screening for alcohol dependence in a walk-in clinic. J. Stud. Alcohol. 1995;56:277–281
  21. Mathalon DH, Pfefferbaum A, Lim KO, Rosenbloom MJ, Sullivan EV. Compounded brain volume deficits in schizophrenia-alcoholism comorbidity. Arch. Gen. Psychiatry. 2003;60:245–252
  22. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am. J. Psychiatry. 1974;131:1121–1123
  23. McCreadie RG Scottish Comorbidity Study Group. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br. J. Psychiatry. 2002;181:321–325
  24. McHugo GJ, Paskus TS, Drake RE. Detection of alcoholism in schizophrenia using the MAST. Alcohol. Clin. Exp. Res. 1993;17:187–191
  25. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr. Bull. 1990;16:31–56
  26. Mueser KT, Yarnold PR, Bellack AS. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr. Scand. 1992;85:48–55
  27. Mueser KT, Nishith P, Tracy JI, DeGirolamo J, Molinaro M. Expectations and motives for substance use in schizophrenia. Schizophr. Bull. 1995;21:367–378
  28. Rabinowitz J, Bromet EJ, Lavelle J, Carlson G, Kovasznay B, Schwartz JE. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychol. Med. 1998;28:1411–1419
  29. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990;264:2511–2518
  30. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke JD, et al. The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch. Gen. Psychiatry. 1988;45:1069–1077
  31. Rosenberg SD, Drake RE, Wolford GL, Mueser KT, Oxman TE, Vidaver RM, et al. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. Am. J. Psychiatry. 1998;155:232–238
  32. Shaner A, Khalsa MA, Roberts L, Wilkins J, Anglin D, Hsieh SC. Unrecognized cocaine use among schizophrenic patients. Am. J. Psychiatry. 1993;150:758–762
  33. Soyka M, Albus M, Kathmann N, Finelli A, Hofstetter S, Holzbach R, et al. Prevalence of alcohol and drug abuse in schizophrenic inpatients. Eur. Arch. Psychiatry Clin. Neurosci. 1993;242:362–372
  34. Steinberg ML, Williams JM, Steinberg HR, Krejci JA, Ziedonis DM. Applicability of the Fagerstrom Test for Nicotine Dependence in smokers with schizophrenia. Addict. Behav. 2005;30:49–59
  35. Wittchen HU. Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI): A critical review. J. Psychiatr. Res. 1994;28:57–84

PII: S0920-9964(05)00456-1

doi: 10.1016/j.schres.2005.09.012

Schizophrenia Research
Volume 81, Issue 2 , Pages 151-155 , 31 January 2006

Article Tools